MARINOL (dronabinol)
For health care professionals: Cannabis and cannabinoids - Canada.ca
Cannabinoids for the treatment of rheumatic diseases — where do we stand? | Nature Reviews Rheumatology
2017-257
Nausea, emesis, and antiemetics - EMCrit Project
View of Role of cannabis in inflammatory bowel diseases | Annals of Gastroenterology
A review on the syntheses of Dronabinol and Epidiolex as classical cannabinoids with various biological activities including those against SARS-COV2 | SpringerLink
MARINOL (dronabinol)
Cannabinoids for the Treatment of Dermatologic Conditions - JID Innovations
The Current State of Pharmacological Treatments for Cannabis Use Disorder and Withdrawal | Neuropsychopharmacology
Towards the use of cannabinoids as antitumour agents | Nature Reviews Cancer
Cardiovascular effects of marijuana and synthetic cannabinoids: the good, the bad, and the ugly | Nature Reviews Cardiology
The Pharmacological Case for Cannabigerol | Journal of Pharmacology and Experimental Therapeutics
The Endogenous Cannabinoid System: A Budding Source of Targets for Treating Inflammatory and Neuropathic Pain | Neuropsychopharmacology
JCM | Free Full-Text | Considerations for Cannabinoids in Perioperative Care by Anesthesiologists | HTML
Cannabinoid Formulations and Delivery Systems: Current and Future Options to Treat Pain | SpringerLink
IJMS | Free Full-Text | Cannabidiol in Neurological and Neoplastic Diseases: Latest Developments on the Molecular Mechanism of Action | HTML
Role of Cannabis and Its Derivatives in Gastrointestinal and Hepatic Disease - Gastroenterology
The use of cannabinoids as anticancer agents - ScienceDirect
Cannabinoid receptor antagonist - Wikipedia
Molecules | Free Full-Text | CB1 Cannabinoid Receptor Signaling and Biased Signaling | HTML
Dronabinol | C21H30O2 - PubChem
